塔莫西芬剂量降级:减少不良影响的有效策略?
Sanne M Buijs1, Stijn L W Koolen2,3, Ron H J Mathijssen2
1Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3015 CN, Rotterdam, The Netherlands. s.buijs@erasmusmc.nl.
降低塔莫西芬剂量可能会减轻乳腺癌患者的不良反应. 本综述探讨了较低剂量他莫西芬的耐受性和疗效,为个性化辅助治疗策略提供了见解.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 塔莫西芬对于雌激素受体阳性乳腺癌辅助疗法至关重要,减少复发和死亡率.
- 标准的每日20毫克的坦莫西芬剂量会引起显著的不良反应,导致高的断药率.
- 从大型试验中关于低剂量他莫西芬在辅助环境中的耐受性和疗效的证据是有限的.
研究的目的:
- 审查现有证据,以减少他莫西芬剂量的耐受性和临床疗效.
- 分析低剂量他莫西芬对副作用和生活质量的影响.
- 评估低剂量他莫西芬在预防乳腺癌方面的疗效.
主要方法:
- 对降低他莫西芬剂量研究进行了广泛的文献搜索.
- 对不良事件发生率和生活质量数据的分析.
- 在预防环境中使用各种终点对临床疗效的评估.
主要成果:
- 低剂量他莫西芬可能会降低与治疗相关的毒性,并改善患者的坚持治疗.
- 关于降低剂量在辅助剂环境中的有效性数据需要进一步调查.
- 该审查提供了减少剂量的实际方法,并建议未来的研究方向.
结论:
- 降低他莫西芬剂量是改善乳腺癌患者耐受性的潜在策略.
- 需要进一步的研究,以建立最佳的低剂量他莫西芬治疗方案,以满足个体患者的需求.
- 个性化剂量策略可以提高治疗坚持性和辅助性他莫西芬治疗的结果.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Desensitization and Tachyphylaxis
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Time Course of Drug Effect
